Cytokine secretion by human mesenchymal stem cells cocultured with damaged corneal epithelial cells

Cytokine

Volumn 46, Issue 1, 2009, Pages 100-103

  Oh, Joo Youn ^a,b   Kim, Mee Kum ^a,b   Shin, Mi Sun ^b   Wee, Won Ryang ^a,b   Lee, Jin Hak ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Biomedical Research Institute   (South Korea)

Author keywords

Angiogenesis; Cornea; Cytokine; Inflammation; Mesenchymal stem cell

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GELATINASE A; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 6; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL DAMAGE; CHEMICAL INJURY; COCULTURE; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA INJURY; CYTOKINE RELEASE; EPITHELIUM CELL; HUMAN; HUMAN CELL; KERATITIS; MESENCHYMAL STEM CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

CELL LINE; CELLS, CULTURED; COCULTURE TECHNIQUES; CORNEA; CYTOKINES; EPITHELIAL CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-6; MESENCHYMAL STEM CELLS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC;

RATTUS;

EID: 62749153736     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.12.011     Document Type: Article

References (21)

1. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
2. Phinney D.G., and Prockop D.J. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 25 (2007) 2896-2902
3. Oh J.Y., Kim M.K., Shin M.S., Lee H.J., Ko J.H., Wee W.R., et al. The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells 26 (2008) 1047-1055
4. Geerling G., Daniels J.T., Dart J.K., Cree I.A., and Khaw P.T. Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells. Invest Ophthalmol Vis Sci 42 (2001) 948-956
5. Aggarwal S., and Pittenger M.F. Human mesenchymal stem cells modulate allogenic immune cell responses. Blood 105 (2005) 1815-1818
6. Djouad F., Charbonnier L.M., Bouffi C., Louis-Plence P., Bony C., Apparailly F., et al. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an Il-6-dependent mechanism. Stem Cells 25 (2007) 2025-2032
7. Ohm J.E., Gabrilovich D.I., Sempowski G.D., Kisseleva E., Parman K.S., Nadaf S., et al. VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression. Blood 101 (2003) 4878-4886
8. Jiang X.X., Zhang Y., Liu B., Zhang S.X., Wu Y., Yu X.D., et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105 (2005) 4120-4216
9. Hedge S., Pahne J., and Smola-Hess S. Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappa B binding activity and CCR7 expression. FASEB J 18 (2004) 1439-1441
10. Li Y., Paczesny S., Lauret E., Poirault S., Bordigoni P., Mekhloufi F., et al. Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. J Immunol 180 (2008) 1598-1608
11. Cursiefen C. Immune privilege and angiogenic privilege of the cornea. Chem Immunol Allergy 92 (2007) 50-57
12. Ma Y., Xu Y., Xiao Z., Yang W., Zhang C., Song E., et al. Reconstruction of chemically burned rat corneal surface by bone marrow-derived human mesenchymal stem cells. Stem Cells 24 (2006) 315-331
13. Ye J., Yao K., and Kim J.C. Mesenchymal stem cell transplantation in a rabbit corneal alkali burn model: engraftment and involvement in wound healing. Eye 20 (2006) 482-490
14. Ye J., Lee S.Y., Kook K.H., and Yao K. Bone marrow-derived progenitor cells promote corneal wound healing following alkali injury. Graefes Arch Clin Exp Ophthalmol 246 (2008) 217-222
15. Azar D.T. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 104 (2006) 264-302
16. Cursiefen C., Masli S., Ng T.F., Dana M.R., Bornstein P., Lawler J., et al. Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis. Invest Ophthalmol Vis Sci 45 (2004) 1117-1124
17. Primo L., Ferrandi C., Roca C., Marchiò S., di Blasio L., Alessio M., et al. Identification of CD36 molecular features required for its in vitro angiostatic activity. FASEB J 19 (2005) 1713-1715
18. Zak S., Treven J., Nash N., and Gutierrez L.S. Lack of thrombospondin-1 increases angiogenesis in a model of chronic inflammatory bowel disease. Int J Colorectal Dis 23 (2007) 297-304
19. Ries C., Egea V., Karow M., Kolb H., Jochum M., and Neth P. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 109 (2007) 4055-4063
20. Taheri F., and Bazan H. Platelet-activating factor overturns the transcriptional repressor disposition of Sp1 in the expression of MMP-9 in human corneal epithelial cells. Invest Ophthalmol Vis Sci 48 (2007) 1931-1941
21. Shin M.S., Hong H.S., Son Y.S., and Kim J.C. Effects of damaged human corneal epithelial cells on differentiation of human mesenchymal stem cell. J Korean Ophthalmol Soc 48 (2007) 423-430